Cargando…

Intensive Systolic Blood Pressure Lowering and Kidney Disease Progression in IgA Nephropathy: A Cohort Study

BACKGROUND: Hypertension has been shown to be an important risk factor in IgA nephropathy (IgAN). The 2021 the Kidney Disease Improving Global Outcomes (KDIGO) Guideline proposes a target systolic blood pressure (SBP) of less than 120 mmHg in patients with Chronic Kidney Disease (CKD) not receiving...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Guizhen, Cheng, Jun, Jiang, Yan, Li, Heng, Li, Xiayu, Chen, Jianghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890476/ https://www.ncbi.nlm.nih.gov/pubmed/35252253 http://dx.doi.org/10.3389/fmed.2022.813603

Ejemplares similares

Urine β2-Microglobulin and Retinol-Binding Protein and Renal Disease Progression in IgA Nephropathy
por: Shen, Xiaoqi, et al.
Publicado: (2021)

Comparison of 24-h Urine Protein, Urine Albumin-to-Creatinine Ratio, and Protein-to-Creatinine Ratio in IgA Nephropathy
por: Yu, Guizhen, et al.
Publicado: (2022)

Plasma D-dimer as a potential predictor of progression in IgA nephropathy: a cohort study
por: Yu, Guizhen, et al.
Publicado: (2023)

Serum phosphorus and calcium levels, and kidney disease progression in immunoglobulin A nephropathy
por: Yu, Guizhen, et al.
Publicado: (2021)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Visit-to-visit variability in blood pressure and kidney disease progression in IgA nephropathy
por: Tang, Chen, et al.
Publicado: (2022)

The Role of Immune Modulation in Pathogenesis of IgA Nephropathy
por: Chang, Sheng, et al.
Publicado: (2020)

Palmoplantar pustulosis and IgA nephropathy
por: Shimamura, Yoshinosuke, et al.
Publicado: (2018)

Overlap of Granulomatosis With Polyangiitis and IgA Nephropathy
por: Zeidan, Bassem S, et al.
Publicado: (2021)

Gut Dysbiosis and Intestinal Barrier Dysfunction Promotes IgA Nephropathy by Increasing the Production of Gd-IgA1
por: Tang, Yuyan, et al.
Publicado: (2022)

Canine IgA nephropathy: a case report
por: YABUKI, Akira, et al.
Publicado: (2015)

Elevated Urinary IL-6 Predicts the Progression of IgA Nephropathy
por: Zhao, Wenjun, et al.
Publicado: (2022)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Fecal Capsule as a Therapeutic Strategy in IgA Nephropathy: A Brief Report
por: Zhi, Wenqiang, et al.
Publicado: (2022)

Octreotide Delaying the Progression of Recurrent IgA Nephropathy After Kidney Transplantation
por: Sharma, Akhil, et al.
Publicado: (2019)

Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change Disease
por: Cho, Won-Hee, et al.
Publicado: (2020)

Ambulatory blood pressure and tubulointerstitial injury in patients with IgA nephropathy
por: Haruhara, Kotaro, et al.
Publicado: (2015)

Prognostic value of chronicity grading on renal outcomes in patients with IgA nephropathy
por: Kang, Donghyuk, et al.
Publicado: (2022)

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
por: Dong, Yaping, et al.
Publicado: (2023)

Overactivation of the complement system may be involved in intrarenal arteriolar lesions in IgA nephropathy
por: Guo, Wei-yi, et al.
Publicado: (2022)

Uncoupling of Glomerular IgA Deposition and Disease Progression in Alymphoplasia Mice with IgA Nephropathy
por: Aizawa, Masashi, et al.
Publicado: (2014)

Clinical Significance of the Intensity of Glomerular Galactose-Deficient IgA1 Deposition in IgA Nephropathy
por: Nakayama, Maiko, et al.
Publicado: (2022)

Noninvasive Urinary Monitoring of Progression in IgA Nephropathy
por: Yang, Joshua Y. C., et al.
Publicado: (2019)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Efficacy and indications of tonsillectomy in patients with IgA nephropathy: a retrospective study
por: Li, Yan, et al.
Publicado: (2022)

Cigarette smoking may accelerate the progression of IgA nephropathy
por: Wang, Siqing, et al.
Publicado: (2021)

Arterial-Arteriolar Sclerosis Is Independently Associated With Poor Renal Outcome in IgA Nephropathy Patients
por: Dong, Lingqiu, et al.
Publicado: (2021)

IgA nephropathy with leucocytoclastic vasculitis
por: Wei, Lin-Yan, et al.
Publicado: (2018)

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
por: Zhao, Na, et al.
Publicado: (2012)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Serum Bilirubin Is Correlated With the Progression of IgA Vasculitis With Nephritis
por: Tan, Jiaxing, et al.
Publicado: (2021)

Association between geriatric nutritional risk index and pathological phenotypes of IgA nephropathy
por: Gan, Yangang, et al.
Publicado: (2023)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Kidney microRNA-21 Expression and Kidney Function in IgA Nephropathy
por: Szeto, Cheuk-Chun, et al.
Publicado: (2020)

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Pyomyositis in a Patient with IgA Nephropathy and Kidney Transplant
por: Xipell, M., et al.
Publicado: (2019)

IgA nephropathy and kidney transplantation according to the Oxford classification
por: Vasconcelos, André de Sá, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6pbko4ajlghtl13p93ttbmaql9